Incidence of Heart Failure, Atrial Fibrillation and Ischaemic Heart Disease in patients with Chronic Obstructive Pulmonary Disease registered with a General Practice within the Mid-Ulster Federation area

Claire Young, Aaron Courtenay

Research output: Contribution to conferencePosterpeer-review

1 Downloads (Pure)

Abstract

Cardiovascular disease (CVD) co-morbidities are one of the most common comorbidities
of Chronic Obstructive Pulmonary Disease (COPD) and have a negative
effect in terms of exacerbations, hospital admissions, quality of life and mortality [1].
CVD co-morbidities are often under-diagnosed and undertreated within the general
COPD population [1]. Research is needed to highlight the prevalence of these
important co-morbidities to all healthcare professionals to improve the rate of their
detection and diagnosis, thus improving management and outcomes for these
patients [1, 2]. The overall aim of this project is to determine the prevalence of AF,
HF, and IHD in patients diagnosed with COPD compared to the general population
registered with a GP within the Mid-Ulster federation of GP practices. Data will also
be examined to determine any effect of gender, age and smoking status on the
prevalence of AF, HF and IHD in patients with a COPD diagnosis.
Original languageEnglish
Publication statusAccepted/In press - 9 May 2024
Event12th International Primary Care Respiratory Group World Conference - Athens, Athens, Greece
Duration: 9 May 202411 May 2024

Conference

Conference12th International Primary Care Respiratory Group World Conference
Abbreviated titleIPCRG
Country/TerritoryGreece
CityAthens
Period9/05/2411/05/24

Fingerprint

Dive into the research topics of 'Incidence of Heart Failure, Atrial Fibrillation and Ischaemic Heart Disease in patients with Chronic Obstructive Pulmonary Disease registered with a General Practice within the Mid-Ulster Federation area'. Together they form a unique fingerprint.

Cite this